A GENOME-DERIVED, EPITOPE-DRIVEN TULAREMIA VACCINE

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI058326-01A1
Agency Tracking Number: AI058326
Amount: $831,922.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
EPIVAX, INC.
EPIVAX, INC., 16 BASSETT ST, PROVIDENCE, RI, 02903
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ANNE Degroot
 (401) 277-3654
 ANNE_DEGROOT@BROWN.EDU
Business Contact
 RONITA FISHER
Phone: (401) 272-2123
Email: FISHERR@EPIVAX.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): EpIVax specializes in the development of epitope-driven vaccines by screening whole genomes for candidate vaccine components. In this application, we describe a rapid approach to the development of a tularemia vaccine

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government